An In-Depth Analysis of Asthma and Emerging Pharmacotherapies for Effective Patient Management


Program Dates: October 25, 2019 - October 24, 2020
Credits: 1.0 AMA PRA Category 1 Credit™


An In-Depth Analysis of Asthma and Emerging Pharmacotherapies for Effective Patient Management

Program Overview

This CME program was derived from content presented at the Eastern Pulmonary Conference 2019 Annual Meeting in Palm Beach, Florida. The expert faculty, Dr. Sidney Braman, will review the pathophysiology and disease burden of asthma to improve patient management. Next, he will delve into the subtypes of asthma and analyze clinical data of novel pharmacotherapies to determine treatment efficacy. Dr. Braman will also analyze the creation and implementation of treatments plans with the interprofessional team to emphasize patient adherence. Upon completion of this CME activity, learners will gain further insight into the emerging pharmacotherapies of asthma for effective patient treatment and management.

Target Audience

Pulmonologists, respiratory specialists, internists, nurse practitioners, nurses and other healthcare professionals who care for patients with asthma

Learning Objectives

  1. Review the pathophysiology, associated comorbidities, and the disease burden of asthma to improve patient diagnostics and management
  2. Discuss the subtypes of asthma and analyze clinical data of novel pharmacotherapies to determine treatment efficacy
  3. Create and implement treatment plans with the interprofessional team, emphasizing patient adherence and improving outcomes

Faculty

Sidney S. Braman, MD
Professor of Medicine
Icahn School of Medicine at Mount Sinai
New York, NY

 

 

Disclosures of Conflict of Interest

It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:

Faculty Relationship Identified With:
Sidney S. Braman, MD Consultant/Advisor: Sunovion Pharmaceuticals Inc.
Speakers Bureau: AstraZeneca Pharmaceuticals; Boehringer Ingelheim; GmbH, Inc; Genentech, Inc.

Planners, Managers, Reviewers

Timothy Hayes, MD, PhD; Nicole Brestowski and Chelsey Benedek hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.

Accreditation Statement

In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Screen Shot 2018-12-11 at 12.19.42 PM

Credit Designation Statements

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.

Participants should claim only the credit commensurate with the extent of their participation in the activity.

Financial Support

This activity has been supported by an independent educational grant from GlaxoSmithKline.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and GlaxoSmithKline do not recommend the use of any agent outside of the labeled indications.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation

1.Read the learning objectives, accreditation information and faculty disclosures at the beginning of this activity.
2. Complete the Pre-Activity Questions
3. Read or Review the activity content.
4. Complete the Post-Activity Test Questions and Evaluation.
5. Learners who receive a grade of 70% or better on the Post-Activity Test Questions and complete the Evaluation will receive appropriate credit as indicated (CME, CNE, and/or CPE credit).
6. Learners should claim only the credit commensurate with the extent of their participation in the activity.

CE Inquiries/Special Needs

For all CE inquiries or special needs, please contact [email protected].

BUTTON

Provided by: AcademicCME-web

Leave a Reply

Your email address will not be published. Required fields are marked *